Suppr超能文献

溶栓后入院时高血糖对卒中结局的影响:与再灌注时间相关的风险分层

Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion.

作者信息

Alvarez-Sabín José, Molina Carlos A, Ribó Marc, Arenillas Juan F, Montaner Joan, Huertas Rafael, Santamarina Esteban, Rubiera Marta

机构信息

Neurovascular Unit, Deparment of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autonoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

出版信息

Stroke. 2004 Nov;35(11):2493-8. doi: 10.1161/01.STR.0000143728.45516.c6. Epub 2004 Oct 7.

Abstract

BACKGROUND AND PURPOSE

We evaluated the impact of admission hyperglycemia (HG) on stroke outcome in relation to the timing of reperfusion in patients treated with tissue plasminogen activator (tPA).

METHODS

We studied 138 consecutive stroke patients with a documented middle cerebral artery (MCA) occlusion treated with intravenous tPA <3 hours of stroke onset. Serum glucose was determined at baseline before tPA administration. HG was defined as a glucose level >140 mg/dL. National Institutes of Health Stroke Scale (NIHSS) scores were obtained at baseline and 24 hour. Transcranial Doppler monitoring of recanalization was conducted during the first 12 hour of stroke onset. mRS was used to assess outcome at 3 months.

RESULTS

Median baseline NIHSS score was 17 points. At baseline, 42 (37.3%) patients were hyperglycemic and 96 (62.7%) normoglycemic. Reperfusion was achieved <3 hours of stroke onset in 32 (23%) patients, between 3 to 6 hours in 49 (36%), 6 to 12 hours in 15 (12%), and in 32 (23%) the MCA remained occluded at 12 hours. A logistic regression model revealed that baseline NIHSS score >16 points (odds ratio [OR], 3.32; 95% CI, 2.18 to 24.7; P=0.032) and admission glucose level >140 mg/dL (OR, 5.65; 95% CI, 1.97 to 16.18; P=0.002) independently predicted poor outcome (modified Rankin scale, 3 to 6) at 3 months. After adjusting by age, stroke severity, site of MCA occlusion, and degree of recanalization, the contribution of HG for poor outcome was higher as shorter the time to reperfusion. The highest odds for poor outcome related to HG corresponded to patients who recanalized <3 hour (OR, 3.1; 95% CI, 1.8 to 14.3; P=0.002), as compared with those who recanalized between 3 and 6 hours (OR, 2.1; 95% CI, 1.1 to 16; P=0.034) and between 6 to 12 hours (OR, 1.1; 95% CI, 0.7 to 21; P=0.43). Moreover, baseline glucose level was negatively correlated (r=-0.45; P=0.001) with the degree of improvement in the NIHSS score at 24 hours after early (<3 hours) but not after delayed (>3 hours) or no recanalization.

CONCLUSIONS

The impact of admission HG on stroke outcome varies depending on the time to tPA-induced reperfusion. The detrimental effect of acute HG is higher after early than after delayed or no reperfusion. Ultra-early glycemic control before reperfusion may improve the efficacy of thrombolytic therapy.

摘要

背景与目的

我们评估了入院时高血糖(HG)对接受组织型纤溶酶原激活剂(tPA)治疗患者的卒中结局的影响,并探讨其与再灌注时间的关系。

方法

我们研究了138例连续的、有记录显示大脑中动脉(MCA)闭塞且在卒中发作<3小时接受静脉tPA治疗的卒中患者。在给予tPA之前测定基线血清葡萄糖。HG定义为血糖水平>140mg/dL。在基线和24小时时获取美国国立卫生研究院卒中量表(NIHSS)评分。在卒中发作的前12小时内进行经颅多普勒再通监测。采用改良Rankin量表(mRS)在3个月时评估结局。

结果

基线NIHSS评分中位数为17分。基线时,42例(37.3%)患者血糖升高,96例(62.7%)血糖正常。32例(23%)患者在卒中发作<3小时实现再灌注,49例(36%)在3至6小时实现再灌注,15例(12%)在6至12小时实现再灌注,32例(23%)在12小时时MCA仍闭塞。逻辑回归模型显示,基线NIHSS评分>16分(比值比[OR],3.32;95%可信区间[CI],2.18至24.7;P = 0.032)和入院血糖水平>140mg/dL(OR,5.65;95%CI,1.97至16.18;P = 0.002)独立预测3个月时预后不良(改良Rankin量表评分,3至6分)。在对年龄、卒中严重程度、MCA闭塞部位和再通程度进行校正后,HG对预后不良的影响随着再灌注时间的缩短而更大。与在3至6小时再通的患者(OR,2.1;95%CI,1.1至16;P = 0.034)和6至12小时再通的患者(OR,1.1;95%CI,0.7至21;P = 0.43)相比,HG与预后不良相关的最高比值比对应于在<3小时再通的患者(OR,3.1;95%CI,1.8至14.3;P = 0.002)。此外,基线血糖水平与早期(<3小时)但非延迟(>3小时)或未再通后24小时NIHSS评分的改善程度呈负相关(r = -0.45;P = 方程0.001)。

结论

入院HG对卒中结局的影响因tPA诱导再灌注的时间而异。急性HG在早期再灌注后的有害作用高于延迟或未再灌注后。再灌注前的超早期血糖控制可能会提高溶栓治疗的疗效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验